NCT05604443 (KKMS39Penta) is a clinical trial of retrospective analyze in Keratoconus, sponsored by Johannes Kepler University of Linz.

Who is sponsoring NCT05604443?

NCT05604443 is sponsored by Johannes Kepler University of Linz.

What drugs are being tested in NCT05604443?

Interventions in NCT05604443: retrospective analyze.

What condition does NCT05604443 study?

NCT05604443 studies Keratoconus.

Is NCT05604443 still recruiting?

NCT05604443 is currently completed. Last updated 13 October 2023.

Last reviewed 2023-10-13 · How we verify

NCT05604443: KKMS39Penta

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Keratoconus Detection Using MS39 and Pentacam

Completed Last updated 13 October 2023

What this trial tests

trial testing retrospective analyze in Keratoconus in 173 participants. Completed in 1 May 2023.

Timeline

28 December 2022

Primary endpoint
1 April 2023

1 May 2023

Quick facts

Lead sponsor	Johannes Kepler University of Linz
Status	Completed
Study type	OBSERVATIONAL
Enrollment	173
Start date	28 December 2022
Primary completion	1 April 2023
Estimated completion	1 May 2023
Sites	1 location across Austria

Drugs / interventions tested

retrospective analyze

Conditions studied

Keratoconus — all drugs for Keratoconus →

Sponsor

Johannes Kepler University of Linz

Who can join

Adults 14 to 100, any sex, with Keratoconus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This retrospective study aims to investigate whether the MS39 and Pentacam are delivering comparable results in the diagnosis of keratoconus. In the future, these measurement devices could be interchangeable in usage.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Keratoconus

Currently open trials in the same condition.

NCT07372911 — PRoTECT: Corneal Wavefront Guided PRK + Epi-off CXL vs. PTK+Epi-off CXL in Keratoconus · NA · recruiting
NCT07461129 — Electrophysiological Changes in Cases of Different Stages of Keratoconus · active not recruiting
NCT06601101 — Effects of Topical Insulin on Corneal Epithelium Healing After Corneal Crosslinking in Patients With Keratoconus · Phase 3 · recruiting
NCT05516004 — Safety and Effectiveness of the PXL-Platinum 330 System for Cornea Crosslinking in Eyes With Cornea Thinning · Phase 2 · recruiting
NCT06798779 — Predicting Manifest Astigmatism in Keratoconus Patients. · active not recruiting

Other Johannes Kepler University of Linz trials

Trials by the same sponsor.

NCT07202767 — Intraocular Lens Calculation Using Artificial Intelligence · not yet recruiting
NCT07210372 — Axial Stability in Short and Long Eyes After Cataract Surgery · completed
NCT06595693 — Tilt Prediction of Clareon Intraocular Lens · completed
NCT05719532 — Core Strength and Coordinative Skills · unknown
NCT05769543 — WATSU and Body Awareness · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05604443 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johannes Kepler University of Linz
Last refreshed: 13 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05604443.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing